Hans Gelderblom, Emanuela Palmerini, Jean-Yves Blay, Michiel van de Sande, Javier Martin Broto, Raul Terés, Madhu Davies, Elyse Seltzer, Sander Veltkamp, Gabriel Tinoco. "A phase 3, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of emactuzumab in patients with tenosynovial giant cell tumor (TANGENT).." Journal of Clinical Oncology (2025). https://doi.org/10.1200/jco.2025.43.16_suppl.tps11584